Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018

References

• Wasserman M, Chapman R, Lapidot R, et al. Twenty-year public health impact of 7- and 13-valent pneumococcal conjugate vaccines in US children. Emerg Infect Dis. 2021;27(6):1627–1636.
   PubMed Web of Science ®Google Scholar
• Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20:45–51.
   PubMed Web of Science ®Google Scholar
• O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902.
   PubMed Web of Science ®Google Scholar
• Curcio D, Cané A, Isturiz R. Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence. Int J Infect Dis. 2015;37:30–35.
   PubMed Web of Science ®Google Scholar
• Senol E, Azap A, Erbay A, et al. Pneumococcal vaccine as one of the immunization coverage targets for adulthood vaccines: a consensus report of the study group for adult immunization of the Turkish Society of Clinical Microbiology and Infectious Diseases. Klimik Dergisi. 2018;31(1):2–18. Turkish.
   Web of Science ®Google Scholar
• Vila-Corcoles A, Ochoa-Gondar O. Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice. Drugs Aging. 2013;30(5):263–276.
   PubMedGoogle Scholar
• Sanford M. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): in older adults. Drugs. 2012;72(9):1243–1255.
   PubMed Web of Science ®Google Scholar
• Jayaraman R, Varghese R, Kumar JL, et al. Invasive pneumococcal disease in Indian adults: 11 years’ experience. J Microbiol Immunol Infect. 2019;52(5):736–742.
   PubMedGoogle Scholar
• Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2000;49(RR-9):1–35.
   Google Scholar
• Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med. 2009;30(02):210–238.
   PubMedGoogle Scholar
• Hasçelik G, Gürler N, Ceyhan M, et al. Serotype distribution and antibiotic resistance among isolates of Streptococcus pneumoniae causing invasive pneumococcal disease in adults in Turkey: 2005-2015. Int J Infect Dis. 2016;45:91.
   Web of Science ®Google Scholar
• T.C. Sağlık Bakanlığı. Genişletilmiş Bağışıklama Programı Genelgesi 2009 [accessed 2022 Oct 23]. Available from: https://www.saglik.gov.tr/TR,11137/genisletilmis-bagisiklama-programi-genelgesi-2009.html
   Google Scholar
• Aile Hekimliği Sözleşme ve Ödeme Yönetmeliği 2021 [accessed 2022 May 25]. Available from: https://www.mevzuat.gov.tr/MevzuatMetin/21.5.4198.pdf
   Google Scholar
• T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu. Risk Grubu Aşılamaları; [accessed 2022 May 25]. Available from: https://asirehberi.saglik.gov.tr/uploads/2017-genelgeler/risk/2-risk-grubu-asilamalari-ek-risk-grubu-asilamalari-1-2.html
   Google Scholar
• T.C. Sağlık Bakanlığı. Sağlık İstatistikleri Yıllığı 2018. Haber Bülteni [accessed 2022 May 25]. Available from: https://sbsgm.saglik.gov.tr/Eklenti/33116/0/haber-bulteni–-2018-30092019pdf.pdf
   Google Scholar
• Mutlu HH, Coşkun FO, Sargın M. The incidence and awareness of vaccination among people aged 65 and over applied to a family medicine outpatient clinic. Ankara Med J. 2018;18:1–13.
   Google Scholar
• Daniels CC, Rogers PD, Shelton CM. A review of pneumococcal vaccines: current polysaccharide vaccine recommendations and future protein antigens. J Pediatr Pharmacol Ther. 2016;21(1):27–35.
   PubMedGoogle Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372(12):1114–1125.
   PubMed Web of Science ®Google Scholar
• Thompson A, Lamberth E, Severs J, et al. Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2019;37(42):6201–6207.
   PubMed Web of Science ®Google Scholar
• Greenberg D, Hoover PA, Vesikari T, et al. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Vaccine. 2018;36(45):6883–6891.
   PubMed Web of Science ®Google Scholar
• Slotved HC, Facklam RR, Fuursted K. Assessment of a novel bile solubility test and MALDI-TOF for the differentiation of Streptococcus pneumoniae from other mitis group streptococci. Sci Rep. 2017;7(1):7167.
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 27th ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Ceyhan M, Aykac K, Gurler N, et al. Serotype distribution of Streptococcus pneumonia in children with invasive disease in Turkey: 2015-2018. Hum Vaccin Immunother. 2020;16(11):2773–2778. Erratum in: Hum Vaccin Immunother. 2021;17(7):2352.
   PubMedGoogle Scholar
• Ceyhan M, Ozsurekci Y, Gürler N, et al. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014. Hum Vaccin Immunother. 2016;12(2):308–313.
   PubMed Web of Science ®Google Scholar
• Geno KA, Gilbert GL, Song JY, et al. Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev. 2015;28(3):871–899. Erratum in: Clin Microbiol Rev. 2020;34(2).
   PubMed Web of Science ®Google Scholar
• Ganaie F, Saad JS, McGee L, et al. A new pneumococcal capsule type, 10d, is the 100th serotype and has a large cps fragment from an oral streptococcus. mBio. 2020;11(3):e00937–e01020.
   Web of Science ®Google Scholar
• Liñares J, Ardanuy C, Pallares R, et al. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect. 2010;16(5):402–410.
   PubMed Web of Science ®Google Scholar
• Furuya Y, Yamagishi Y, Okade H, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan, 2008-2016. J Infect Chemother. 2017;23(6):394–399.
   PubMed Web of Science ®Google Scholar
• Stanek RJ, Norton NB, Mufson MA. A 32-year study of the effect of pneumococcal vaccines on invasive Streptococcus pneumoniae disease. Am J Med Sci. 2016;352(6):563–573.
   PubMed Web of Science ®Google Scholar
• Hauser C, Kronenberg A, Allemann A, et al. Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014. Euro Surveill. 2016;21(21):1–10.
   Google Scholar
• European Centre for Disease Prevention and Control (ECDC). Invasive pneumococcal disease - annual epidemiological report for 2016; 2016 [accessed 2022 May 25]. Available from: https://www.ecdc.europa.eu/en/publications-data/invasive-pneumococcal-disease-annual-epidemiological-report-2016
   Google Scholar
• Cui YA, Patel H, O'Neil WM, et al. Pneumococcal serotype distribution: a snapshot of recent data in pediatric and adult populations around the world. Hum Vaccin Immunother. 2017;13:1–13.
   Web of Science ®Google Scholar
• U.S. Food and Drug Administration; [accessed 2022 May 25]. Available from: https://www.fda.gov/
   Google Scholar
• European Medicines Agency; [accessed 2022 May 25]. Available from: https://www.ema.europa.eu/en
   Google Scholar
• de Roux A, Schmöle-Thoma B, Siber GR, et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis. 2008;46(7):1015–1023. Erratum in: Clin Infect Dis. 2008;46:1488.
   PubMed Web of Science ®Google Scholar